CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
Vaughn J, Brown S, Papadopoulos E, Jakubowski A, Tamari R, Giralt S, Ponce D, Cho C, Perales M, Shaffer B, Gyurkocza B. CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era. Bone Marrow Transplantation 2022, 57: 1740-1742. PMID: 36076011, DOI: 10.1038/s41409-022-01783-7.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, CD34Hematopoietic Stem Cell TransplantationHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsProtein-Tyrosine Kinases